• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阻塞性睡眠呼吸暂停患者循环 P-选择素糖蛋白配体 1 和 P-选择素水平。

Circulating P-Selectin Glycoprotein Ligand 1 and P-Selectin Levels in Obstructive Sleep Apnea Patients.

机构信息

Department of Pulmonology, Semmelweis University, Tömő utca 25-29, Budapest, Hungary.

Department of Radiology, Semmelweis University, Budapest, Hungary.

出版信息

Lung. 2020 Feb;198(1):173-179. doi: 10.1007/s00408-019-00299-0. Epub 2020 Jan 2.

DOI:10.1007/s00408-019-00299-0
PMID:31897593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7012996/
Abstract

PURPOSE

Obstructive sleep apnea (OSA) is characterized by chronic intermittent hypoxia which induces inflammation in blood vessels leading to the development of cardiovascular comorbidities. Several studies implicated the role of P-selectin in vascular inflammation of OSA. P-selectin glycoprotein ligand 1 (PSGL-1) is the main activator for P-selectin and is involved in immune cell trafficking. However, PSGL-1 has not been analyzed in OSA. The aim of the study was to investigate plasma PSGL-1 and P-selectin levels to have a deeper understanding on their interaction in obstructive sleep apnea.

METHODS

Fifty-one untreated patients with OSA and 42 non-OSA controls were recruited. Plasma PSGL-1 levels were determined in evening and morning samples, P-selectin levels were analyzed in morning samples using commercially available ELISA kits. Polysomnography was performed in all participants. OSA was defined by an apnea-hypopnea index ≥ 5/h.

RESULTS

PSGL-1 levels did not differ between controls and OSA patients either in the evening or in the morning. Although, there was no difference between controls (16.9/6.8-40.8 ng/ml) and patients with OSA (19.6/8.4-56.8, p = 0.24), patients with severe OSA had increased plasma P-selectin levels (25.6/8.4-56.8 ng/ml) compared to mild OSA patients (14.1/8.5-35.3 ng/ml, p = 0.006) and controls (p = 0.03).

CONCLUSIONS

P-selectin expression relates to disease severity suggesting a pathophysiological role in endothelial cell activation. PSGL-1 levels are unaltered in OSA, suggesting an alternative activation pathway for P-selectin in OSA.

摘要

目的

阻塞性睡眠呼吸暂停(OSA)的特征是慢性间歇性缺氧,这会导致血管炎症,从而引发心血管合并症。有几项研究表明 P-选择素在 OSA 的血管炎症中起作用。P-选择素糖蛋白配体 1(PSGL-1)是 P-选择素的主要激活剂,参与免疫细胞的迁移。然而,PSGL-1 在 OSA 中尚未被分析。本研究旨在探讨血浆 PSGL-1 和 P-选择素水平,以更深入地了解它们在阻塞性睡眠呼吸暂停中的相互作用。

方法

招募了 51 名未经治疗的 OSA 患者和 42 名非 OSA 对照组。使用商业 ELISA 试剂盒在晚上和早上样本中测定血浆 PSGL-1 水平,在早上样本中分析 P-选择素水平。所有参与者均进行了多导睡眠图检查。OSA 定义为每小时呼吸暂停-低通气指数≥5。

结果

无论是在晚上还是在早上,PSGL-1 水平在对照组和 OSA 患者之间均无差异。尽管对照组(16.9/6.8-40.8ng/ml)和 OSA 患者(19.6/8.4-56.8ng/ml,p=0.24)之间无差异,但重度 OSA 患者的血浆 P-选择素水平升高(25.6/8.4-56.8ng/ml)与轻度 OSA 患者(14.1/8.5-35.3ng/ml,p=0.006)和对照组(p=0.03)相比。

结论

P-选择素的表达与疾病严重程度相关,提示其在血管内皮细胞激活中的病理生理作用。OSA 中 PSGL-1 水平不变,提示 OSA 中 P-选择素的替代激活途径。

相似文献

1
Circulating P-Selectin Glycoprotein Ligand 1 and P-Selectin Levels in Obstructive Sleep Apnea Patients.阻塞性睡眠呼吸暂停患者循环 P-选择素糖蛋白配体 1 和 P-选择素水平。
Lung. 2020 Feb;198(1):173-179. doi: 10.1007/s00408-019-00299-0. Epub 2020 Jan 2.
2
Circulating P-Selectin and Its Glycoprotein Ligand in Nondiabetic Obstructive Sleep Apnea Patients.非糖尿病阻塞性睡眠呼吸暂停患者循环中的P-选择素及其糖蛋白配体
Adv Exp Med Biol. 2020;1279:61-69. doi: 10.1007/5584_2020_501.
3
Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea.冠状动脉疾病合并中重度阻塞性睡眠呼吸暂停患者的黏附分子
Chest. 2002 May;121(5):1541-7. doi: 10.1378/chest.121.5.1541.
4
Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation.阻塞性睡眠呼吸暂停中核因子κB的激活:一条导致全身炎症的途径。
Sleep Breath. 2006 Mar;10(1):43-50. doi: 10.1007/s11325-005-0046-6.
5
Circadian variability of fibrinolytic markers and endothelial function in patients with obstructive sleep apnea.阻塞性睡眠呼吸暂停患者纤溶标志物和内皮功能的昼夜变异性。
Sleep. 2014 Feb 1;37(2):359-67. doi: 10.5665/sleep.3414.
6
Plasma selectins in patients with obstructive sleep apnea.阻塞性睡眠呼吸暂停患者的血浆选择素。
Adv Exp Med Biol. 2013;756:113-9. doi: 10.1007/978-94-007-4549-0_15.
7
The impact of OSA and CPAP treatment on cell adhesion molecules' night-morning variation.阻塞性睡眠呼吸暂停(OSA)及持续气道正压通气(CPAP)治疗对细胞黏附分子昼夜变化的影响。
Sleep Breath. 2021 Sep;25(3):1301-1307. doi: 10.1007/s11325-020-02232-9. Epub 2020 Oct 26.
8
Silent brain infarction and platelet activation in obstructive sleep apnea.阻塞性睡眠呼吸暂停中的无症状脑梗死与血小板活化
Am J Respir Crit Care Med. 2007 Mar 15;175(6):612-7. doi: 10.1164/rccm.200608-1141OC.
9
Obstructive Sleep Apnea Severity, Body Mass Index, and Circulating Levels of Cellular Adhesion Molecules.阻塞性睡眠呼吸暂停严重程度、体重指数与循环细胞黏附分子水平
Lung. 2020 Dec;198(6):939-945. doi: 10.1007/s00408-020-00401-x. Epub 2020 Nov 3.
10
The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea.间歇低氧血症对肥胖阻塞性睡眠呼吸暂停患者血小板活化的影响。
J Clin Sleep Med. 2011 Apr 15;7(2):172-8.

引用本文的文献

1
A possible important regulatory role of estrogen in obstructive sleep apnea hypoventilation syndrome.雌激素在阻塞性睡眠呼吸暂停低通气综合征中可能具有的重要调节作用。
Front Med (Lausanne). 2025 Mar 3;12:1369393. doi: 10.3389/fmed.2025.1369393. eCollection 2025.
2
Clinical significance of elevated soluble T-cell immunoglobulin and mucin domain 1 and soluble P-selectin in individuals with obstructive sleep apnea-hypopnea syndrome.可溶性 T 细胞免疫球蛋白和粘蛋白结构域 1 及可溶性 P 选择素在阻塞性睡眠呼吸暂停低通气综合征患者中的临床意义。
Saudi Med J. 2023 Nov;44(11):1113-1119. doi: 10.15537/smj.2023.44.11.20230452.
3
PSGL-1: a novel immune checkpoint driving T-cell dysfunction in obstructive sleep apnea.

本文引用的文献

1
Circulating Survivin Levels in Obstructive Sleep Apnoea.阻塞性睡眠呼吸暂停中循环生存素水平。
Lung. 2018 Aug;196(4):417-424. doi: 10.1007/s00408-018-0120-z. Epub 2018 May 8.
2
PSGL-1: A New Player in the Immune Checkpoint Landscape.PSGL-1:免疫检查点领域的新角色。
Trends Immunol. 2017 May;38(5):323-335. doi: 10.1016/j.it.2017.02.002. Epub 2017 Mar 2.
3
P-selectin glycoprotein ligand-1 in T cells.T细胞中的P-选择素糖蛋白配体-1
P选择素糖蛋白配体-1:一种导致阻塞性睡眠呼吸暂停中T细胞功能障碍的新型免疫检查点。
Front Immunol. 2023 Oct 3;14:1277551. doi: 10.3389/fimmu.2023.1277551. eCollection 2023.
4
The link between the sphingolipid rheostat and obstructive sleep apnea.鞘脂类变阻器与阻塞性睡眠呼吸暂停之间的联系。
Sci Rep. 2023 May 11;13(1):7675. doi: 10.1038/s41598-023-34717-4.
5
Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia.阻塞性睡眠呼吸暂停与脂质代谢:阻塞性睡眠呼吸暂停相关血脂异常病理生理学的证据总结与未来展望
Biomedicines. 2022 Oct 29;10(11):2754. doi: 10.3390/biomedicines10112754.
6
The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review.P 选择素在 COVID-19 凝血功能障碍中的作用:最新综述。
Int J Mol Sci. 2021 Jul 26;22(15):7942. doi: 10.3390/ijms22157942.
7
Obstructive Sleep Apnea, Hypercoagulability, and the Blood-Brain Barrier.阻塞性睡眠呼吸暂停、高凝状态与血脑屏障
J Clin Med. 2021 Jul 14;10(14):3099. doi: 10.3390/jcm10143099.
8
Soluble P-selectin levels in patients with obstructive sleep apnea: a systematic review and meta-analysis.阻塞性睡眠呼吸暂停患者可溶性 P 选择素水平:系统评价和荟萃分析。
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4633-4644. doi: 10.1007/s00405-021-06831-4. Epub 2021 May 5.
9
Coagulation and Fibrinolysis in Obstructive Sleep Apnoea.阻塞性睡眠呼吸暂停中的凝血和纤溶。
Int J Mol Sci. 2021 Mar 11;22(6):2834. doi: 10.3390/ijms22062834.
10
LUNG Year in Review: 2020.《肺部年度回顾:2020》
Lung. 2021 Feb;199(1):1-5. doi: 10.1007/s00408-021-00418-w. Epub 2021 Jan 26.
Curr Opin Hematol. 2017 May;24(3):265-273. doi: 10.1097/MOH.0000000000000331.
4
Diurnal variation of circulating microvesicles is associated with the severity of obstructive sleep apnoea.循环微泡的昼夜变化与阻塞性睡眠呼吸暂停的严重程度相关。
Sleep Breath. 2017 Sep;21(3):595-600. doi: 10.1007/s11325-017-1464-y. Epub 2017 Jan 27.
5
CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea.持续气道正压通气治疗阻塞性睡眠呼吸暂停对心血管事件的预防作用。
N Engl J Med. 2016 Sep 8;375(10):919-31. doi: 10.1056/NEJMoa1606599. Epub 2016 Aug 28.
6
Chronic intermittent hypoxia exposure-induced atherosclerosis: a brief review.慢性间歇性低氧暴露诱导的动脉粥样硬化:简要综述
Immunol Res. 2015 Dec;63(1-3):121-30. doi: 10.1007/s12026-015-8703-8.
7
Reduced systemic levels of IL-10 are associated with the severity of obstructive sleep apnea and insulin resistance in morbidly obese humans.在病态肥胖人群中,全身IL-10水平降低与阻塞性睡眠呼吸暂停的严重程度及胰岛素抵抗相关。
Mediators Inflamm. 2015;2015:493409. doi: 10.1155/2015/493409. Epub 2015 Apr 6.
8
Inflammation in sleep apnea: an update.睡眠呼吸暂停中的炎症:最新进展。
Rev Endocr Metab Disord. 2015 Mar;16(1):25-34. doi: 10.1007/s11154-014-9304-x.
9
Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA.炎症标志物:CPAP 治疗轻度症状性 OSA 的 MOSAIC 随机试验数据。
Thorax. 2015 Feb;70(2):181-2. doi: 10.1136/thoraxjnl-2014-205958. Epub 2014 Sep 2.
10
Modulation of inflammatory and hemostatic markers in obstructive sleep apnea patients treated with mandibular advancement splints: a parallel, controlled trial.下颌前移矫治器治疗阻塞性睡眠呼吸暂停患者对炎症和止血标志物的调节作用:一项平行对照试验。
J Clin Sleep Med. 2014 Mar 15;10(3):255-62. doi: 10.5664/jcsm.3522.